| 51 |
33112809 | Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations. | 2020 Oct |
1 |
| 52 |
33233840 | New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis. | 2020 Nov 20 |
2 |
| 53 |
33257569 | FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho. | 2020 Dec 15 |
1 |
| 54 |
33306729 | Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study. | 2020 |
2 |
| 55 |
33374582 | Caloric Intake in Renal Patients: Repercussions on Mineral Metabolism. | 2020 Dec 23 |
1 |
| 56 |
33424930 | Association of Fibroblast Growth Factor 23 With Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study. | 2020 |
2 |
| 57 |
29602956 | Effects of vitamin D supplementation on FGF23: a randomized-controlled trial. | 2019 Mar |
1 |
| 58 |
30456544 | Vitamin D deficiency, endothelial function and bone biomarkers in post-kidney transplantation patients from North India. | 2019 Jan |
1 |
| 59 |
30613854 | The first Korean case report with scaphocephaly as the initial sign of X-linked hypophosphatemic rickets. | 2019 Jun |
2 |
| 60 |
30778159 | Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients. | 2019 Feb 18 |
1 |
| 61 |
30813741 | Biological variation of intact fibroblast growth factor 23 measured on a fully automated chemiluminescent platform. | 2019 May |
2 |
| 62 |
30909513 | FGF23, Biomarker or Target? | 2019 Mar 22 |
1 |
| 63 |
31035488 | Questioning the Safety of Calcidiol in Hemodialysis Patients. | 2019 Apr 26 |
1 |
| 64 |
31037817 | Clearance of FGF-23 during continuous renal replacement therapy. | 2019 Jul |
1 |
| 65 |
31044263 | High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis. | 2019 Aug |
3 |
| 66 |
31058117 | Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension. | 2019 |
2 |
| 67 |
31261249 | Phosphaturic Mesenchymal Tumor of Soft Tissue of the Foot: Report of a Case With Review of the Literature. | 2019 Sep |
1 |
| 68 |
31372708 | Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis. | 2019 Nov |
10 |
| 69 |
31377240 | Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. | 2019 Oct |
1 |
| 70 |
31461904 | The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia. | 2019 Aug 27 |
1 |
| 71 |
31465293 | The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study. | 2019 Nov 26 |
6 |
| 72 |
31485552 | FGF23, Hypophosphatemia, and Emerging Treatments. | 2019 Aug |
3 |
| 73 |
31495905 | The FGF metabolic axis. | 2019 Oct |
1 |
| 74 |
31599133 | FGF23 and Associated Disorders of Phosphate Wasting. | 2019 Sep |
1 |
| 75 |
31905439 | Skeletal mineralization: mechanisms and diseases. | 2019 Dec |
2 |
| 76 |
31949415 | Is hepcidin related with anemia and bone mineral metabolism in children with non-dialysis chronic kidney disease? | 2019 |
1 |
| 77 |
28087977 | Fibroblast growth factor 23 in untreated nephrotic syndrome. | 2018 Apr |
1 |
| 78 |
28795342 | Effect of Cholecalciferol therapy on serum FGF23 in vitamin D deficient patients: a randomized clinical trial. | 2018 Mar |
3 |
| 79 |
29342138 | α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. | 2018 Jan 25 |
1 |
| 80 |
29481636 | Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease. | 2018 Dec 1 |
2 |
| 81 |
29519954 | Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients. | 2018 Apr 6 |
2 |
| 82 |
29574933 | The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients. | 2018 Jul |
3 |
| 83 |
29621752 | Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline. | 2018 |
2 |
| 84 |
29633705 | Early postoperative measurement of fibroblast growth factor 23 predicts severe acute kidney injury in infants after cardiac surgery
. | 2018 Sep |
2 |
| 85 |
29660161 | The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals. | 2018 Nov |
2 |
| 86 |
29679282 | Burosumab: First Global Approval. | 2018 Apr |
1 |
| 87 |
29760049 | Insulin suppresses the production of fibroblast growth factor 23 (FGF23). | 2018 May 29 |
2 |
| 88 |
29886473 | [Correlation of fibroblast growth factor 23 with
adverse prognosis of chronic kidney disease and
therapy strategy]. | 2018 May 28 |
1 |
| 89 |
29946298 | Role of Fibroblast Growth Factor-23 in Innate Immune Responses. | 2018 |
2 |
| 90 |
29996975 | The interrelation between FGF23 and glucose metabolism in humans. | 2018 Sep |
1 |
| 91 |
30041203 | Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels. | 2018 |
2 |
| 92 |
30134801 | Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study. | 2018 May 30 |
3 |
| 93 |
30217676 | FGF23 beyond Phosphotropic Hormone. | 2018 Nov |
1 |
| 94 |
30217807 | Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. | 2018 Oct |
3 |
| 95 |
30269115 | [Rickets/Osteomalacia. Action of FGF23.] | 2018 |
1 |
| 96 |
30380963 | Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23). | 2018 Nov - Dec |
1 |
| 97 |
27017221 | Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children. | 2017 Mar |
1 |
| 98 |
27622885 | FGF23-Klotho signaling axis in the kidney. | 2017 Jul |
2 |
| 99 |
28063327 | Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis. | 2017 Mar |
1 |
| 100 |
28110703 | Plant-based diets relatively low in bioavailable phosphate and calcium may aid prevention and control of prostate cancer by lessening production of fibroblast growth factor 23. | 2017 Feb |
2 |